Pharmacology and upper limb poststroke spasticity: A Review;Spasticité du membre supérieur aprés AVC, traitements pharmacologiques. Revue

Annales de Readaptation et de Medecine Physique

Volumn 47, Issue 8, 2004, Pages 575-589

  Yelnik, A P ^a  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

Botulinum toxin; Hemiplegia; H mipl gie; Membre sup rieur; Pharmacological treatments; Spasticit ; Spasticity; Toxine botulique; Traitements pharmacologiques; Upper limb

Indexed keywords

ALCOHOL; BACLOFEN; BOTULINUM TOXIN; BOTULINUM TOXIN A; DANTROLENE; PHENOL; PLACEBO; TIZANIDINE;

ARM DISEASE; DEPRESSION; DRUG EFFICACY; DRUG MECHANISM; HUMAN; KINESIOTHERAPY; MEDICAL LITERATURE; MEDICAL SOCIETY; MEDLINE; NEUROLYSIS; NEUROMUSCULAR BLOCKING; OCCUPATIONAL THERAPY; PECTORALIS MAJOR MUSCLE; REVIEW; SIDE EFFECT; SKELETAL MUSCLE; SOMNOLENCE; SPASTICITY; STROKE; TREATMENT OUTCOME;

EID: 4744376546     PISSN: 01686054     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annrmp.2004.05.019     Document Type: Article

References (69)

1. Albany K. Physical and occupational therapy considerations in adult patients receiving botulinum toxin injections for spasticity Muscle Nerve S6 1997 S221 S231
2. Bakheit A.M.O., Thilmann A.F., Ward A.B., Poewe W., Wissel J., and Muller J. A randomized double-blind, placebo-controlled, dose-ranging study to compare the efficacy and safety of three doses of Botulinum Toxin Type A (Dysport) with placebo in upper limb spasticity after stroke Stroke 31 2000 2402 2406
3. Bakheit A.M., Pittock S., Moore A.P., Wurker M., Otto S., Erbguth F., and Coxon L. A randomized, double-blind, placebo-controlled study of the efficacy and safety of botulinum toxin type A in upper limb spasticity in patients with stroke Eur J Neurol 8 2001 559 565
4. Bakheit A.M.O., and Sawyer J. The effects of botulinum toxin treatment on associated reactions of the upper limb on hemiplegic gait - a pilot study Disability and rehabilitation 24 2002 519 522
5. Barnes M.P. Experience of botulinum toxin in the management of spasticity Eur J Neurology 4 1997 S33 S36
6. Bes A., Eyssette M., Pierrot-Deseilligny E., Rohmer F., and Warter J.M. A multi-centre, double-blind trial of tizanidine, a new antispastic agent, in spasticity associated with hemiplegia Curr Med Res Opin 10 1988 709 718
7. Bhakta B.B., Cozens J.A., Bamford J.M., and Chamberlain M.A. Use of botulinum toxin in stroke patients with severe upper limb spasticity J Neurol Neurosurg Psychiatry 61 1996 30 35
8. Bhakta B.B., Cozens J.A., Chamberlain M.A., and Bamford J.M. Impact of botulinum toxin type A on disability and carer burden due to arm spasticity after stroke: a randomized double blind placebo controlled trial J. Neurol Neurosurg Psychiatry 69 2000 217 221
9. Brashear A., Gordon M.F., Elovic E., Kassicieh D., Marciniak C., Do M., Lee C.H., Jenkins S., and Turkel C. Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after a stroke N Engl J Med 347 2002 395 400
10. Brashear A., Mc Afee A.L., Kuhn E.R., and Ambrosius W.T. Treatment with botulinum toxin type B for upper-limb spasticity Arch Phys Med Rehabil 84 2003 103 107
11. Braun R.M., Hoffer M.M., Mooney V., McKeever J., and Roper B. Phenol nerve block in the treatment of acquired spastic hemiplegia in the upper limb J Bone Joint Surg (Am) 55 1973 580 585
12. Dunne J.W., Heye N., and Dunne S.L. Treatment of chronic limb spasticity with botulinum toxin A J Neurol Neurosurg Psychiatry 58 1995 232 235
13. Emery E. Interthecal baclofen. Literature review of the results and complications Neurochirurgie 49 2003 276 288
14. Filipetti P., and Decq P. Interest of anesthesic blocks for assessment of the spastic patient. A series of 815 motor blocks Neurochirurgie 49 2003 226 238
15. Francisco G.E. Intrathecal baclofen therapy for stroke-related spasticity Topics in Stroke Rehabilitation 2001 36 46 Ed Spring
16. Francisco G.E. Can intrathecal baclofen therapy unleash functional recovery after stroke? Stroke 32 2001 2108 2109
17. Francisco G.E., Boake C., and Vaughn A. Botulinum toxin in upper limb spasticity after acquired brain injury. A randomized trial comparing dilution techniques Am J Phys Med Rehabil 81 2002 355 363
18. Garland D.E., Lucie R.S., and Waters R.L. Current uses of open phenol nerve block for adult acquired spasticity Clin Orthop 165 1982 217 222
19. Gelber D.A., Good D.C., Dromerick A., Sergay S., and Richardson M. Open-label dose-titration safety and efficacy study of Tizanidine hydrochloride in the treatment of spasticity Stroke 32 2001 1841 1846
20. Girlanda P., Quartarone A., Sinicropi S., Nicolosi C., Roberto M.L., and Picciolo G. Botulinum toxin in upper limb spasticity: study of reciprocal inhibition between forearm musles NeuroReport 8 1997 3039 3044
21. Gordon M.F., Brashear A., Elovic E., Kassicieh D., Marciniak C., and Gonzaga-Camfield R. A multicenter, open-label study of the safety and efficacy of repeated botulinum toxin type A doses in poststroke, focal, upper limb spasticity Neurology 58 7 2002 A221
22. Gracies J.M., Elovic E., Mc Guire J., and Simpson D.M. Traditional Pharmacological Treatments for spasticity part I: local treatments Muscle Nerve S6 1997 61 92
23. Gracies J.M., Nance P., Elovic E., Mc Guire J., and Simpson D.M. Traditional Pharmacological Treatments for spasticity part II: general and regional treatments Muscle Nerve S6 1997 92 120
24. Gracies J.M., Flanagan S., Weisz D.J., Yang B.Y., and Simpson D. Haute dilution de toxine botulique et ciblage de la plaque motrice dans la spasticité au membre supérieur. Ètude en double insu. Com Congr̀s SOFMER Ann Readapt Med Phys 46 2003 428
25. Grazko M.A., Polo K.B., and Jabbari B. Botulinum toxin A for spasticity, muscle spasms, and rigidity Neurology 45 1995 712 717
26. Hecht J.S. Subscapular nerve block in the painful hemiplegic shoulder Arch Phys Med Rehabil 73 1992 1036 1039
27. Hesse S., Reiter F., Konrad M., and Jahnke M.T. Botulinum toxin type A and short-term electrical stimulation in the treatment of upper limb flexor spasticity after stroke: a randomized, double-blind, placebo-controlled trial Clin Rehabil 12 1998 381 388
28. Hurvitz A.E., Conti G.E., and Brown S.H. Changes in movement characteristics of spastic upper extremity after botulinum toxin injection Arch Phys Med Rehabil 84 2003 444 454
29. Katrak P.H., Cole A., Poulos C.J., and Mc Cauley J.C.K. Objective assessment of spasticity, strength and function with early exhibition of Dantrolene Sodium after cerebrovascular accident: a randomized double-blind study Arch Phys Med Rehabil 73 1992 4 9
30. Keenan M.A., Todderaud E.P., Henderson R., and Botte M. Management of intrinsic spasticity in the hand with phenol injection or neurectomy of the motor branch of the ulnar nerve J. Hand Surg 12A 1987 734 739
31. Keenan M.A., Tomas E.S., Stone L., and Gersten L.M. Percutaneous phenol block of the musculocutaneous nerve to control elbow flexor spasticity J Hand Surg (Am) 15 1990 340 346
32. Ketel W.B., and Kolb M.E. Long-term treatment with dantrolene sodium of stroke patients with spasticity limiting the return of function Curr Med Res Opin 9 1984 161 169
33. Kirazli Y., On A.Y., Kismali B., and Aksit R. Comparison of phenol block and botulinum toxin type a in the treatment of spastic foot after stroke. A randomized, double-blind trial Arch Phys Med Rehabil 77 1998 510 515
34. Kong K.H., and Chua K.S.G. Neurolysis of the musculocutaneous nerve with alcohol to treat post stroke elbow flexor spasticity Arch Phys Med Rehabil 80 1999 1234 1236
35. Kong K.H., and Chua K.S.G. Intramuscular neurolysis with alcohol to treat post stroke finger flexor spasticity Clinical Rehabil 16 2002 378 381
36. Lagalla G., Danni M., Reiter F., Ceravolo M.G., and Provinciali L. Post-stroke spasticity management with repeated botulinum toxin injections in the upper limb Am J Phys Med Rehabil 79 2000 377 384
37. Mc Guire J.R. Effective use of chemodenervation and chemical neurolysis in the management of post stroke spasticity Topics in Stroke Rehabilitation 2001 47 55 Spring
38. Meythaler J.M., Guin-Renfroe S., Johnson A., and Brunner R.M. Prospective assessment of Tizaridine for spasticity due to acquired brain injury Arch Phys Med Rehabil 82 2001 1155 1163
39. Meythaler J.M., Guin-Renfroe S., Brunner R.C., and Hadley M.N. Intrathecal Baclofen for spastic hypertonia from stroke Stroke 32 2001 2099 2109
40. Milanov I., and Georgien D. Mechanisms of Tizanidine action on spasticity Acta Neurol Scand 89 1994 274 279
41. Miscio G., Del Conte C., Piance D., Colombo R., Panizza M., Schieppati M., and Pisano F. Botulinum toxin in post-stroke patients: stiffness modifications and clinical implications J Neurol 25 2004 189 196
42. O'brien C.F., Seeberger L.C., and Smith D.B. Spasticity after stroke epidemiology adoptional treatment Drugs Aging 9 1996 332 340
43. Palmer D.T., Horn L.J., and Harmon R.L. Botulinum toxin treatment of lumbrical spasticity Am J Phys Med Rehabil 77 1998 348 350
44. Pandyan A.D., Vuadens P., Van Wijck F.M.J., Stark S., Johnson G.R., and Barnes M.P. Are we underestimating the clinical efficacy of botulium toxin (typeA)? Quantifying changes in spasticity, strength and upper limb function after injections of Botox to the elbow flexors in a unilateral stroke population Clin Rehabil 16 2002 654 660
45. Panizza M., Castagna M., Di Summa A., Saibene L., Grioni G., and Nilson J. Functional and clinical changes in upper limb spastic patients treated with botulinum toxin (BTX) Funct Neurol 15 2000 147 155
46. Park E.S., Park C.I., Kim D.Y., and Kim Y.R. The effect of spasticity on cortical somatosensory-evoked potentials: changes of cortical somatosensory-evoked potentials after botulinum toxin type A injection Arch Phys Med Rehabil 83 2002 1592 1596
47. Pelissier J., Viel E., Enjalbert M., Kotzki N., and Eledjam J.J. Chemical neurolysis using alcohol in the treatment of spasticity in the hemiplegic Cah Anesthesiol 41 1993 139 143
48. Pierson S.H., Katz D.I., and Tarsy D. Botulinum toxin A in the treatment of spasticity: functional implications and patient selection Arch Phys Med Rehabil 77 1996 717 721
49. Pinder R.M., Brogden R.N., Speight T.M., and Avery G.S. Dantrolene sodium: A review of its pharmacological properties and therapeutic efficacy in spasticity Drugs 13 1977 3 23
50. Richardson D., Sheean G., Werring D., Desai M., Edwards S., and Greenwood R. Evaluating the role of botulinum toxin in the management of focal hypertonia in adults J Neurol Neurosurg Psychiatry 69 2000 499 506
51. Rode G., Maupas E., Luaute J., Courtois-Jacquin S., and Boisson D. Medical treatment of spasticity Neuroch 49 2003 247 255
52. Rodriquez A.A., McGinn M., and Chappell R. Botulinum toxin injection of spastic finger flexors in hemiplegic patients Am J Phys Med Rehabil 79 2000 44 47
53. Rousseaux M., Kozlowzi O., and Froger J. Efficacy of botulinum toxin A in upper limb function of hemiplegic patients J Neurol 249 2002 76 84
54. Rousseaux M., Launay M.J., and Kozlowski O. Hémiplégie vasculaire: intérêt de l'injection de toxine botulique au membre supérieur Ann Readapt Med Phys 46 2003 286 295
55. Sampaio C., Ferreira J.J., Pinto A.A., Crespo M., Ferro J.M., and Castro-Caldas A. Botulinum toxin type A for the treatment of arm and hand spasticity in stroke patients Clin rehabil 11 1997 3 7
56. Sampson F.C., Hayward A., Evans G., Morton R., and Collett B. Functional benefits and cost/benefit analysis of intrathecal baclofen infusion for the management of severe spasticity J. Neurosurg 96 2002 1052 1057
57. Shekelle P.G., Woolf S.H., Eccles M., and Grimshaw J. Clinical guidelines developing clinical guidelines BMJ 318 1999 593 596
58. Simpson D.M., Alexander D.N., O'Brien C.F., Tagliati M., Aswad A.S., and Leon J.M. Botulinum toxin type A in the treatment of upper extremity spasticity: a randomized, double-blind, placebo-controlled trial Neurology 46 1996 1306 1310
59. Smith S.J., Ellis E., White S., and Moore A.P. A double-blind placebo-controlled study of botulinum toxin in upper limb spasticity after stroke or head injury Clinical Rehabilitation 14 2000 5 13
60. Stark S.C. Physiotherapy and botulinum toxin in spasticity management Brit J therap rehabil 8 2001 386 392
61. Tardieu G., Tardieu C., Hariga J., and Gagnard L. Treatment of spasticity by injection of diluted alcohol at the motor point or by epidural route. Clinical extension of an experiment on the decerebrated cat Dev Med Child Neurol. 10 1968 555 568
62. Van Kuijk A.A., Geurts A.C.H., Bevaart B.J.W., and Van Limbeek J. Treatment of upper extremity spasticity in stroke patients by focal neuronal or neuromuscular blockade: a systematic review of the literature J Rehabil Med 34 2002 51 61
63. Viriyavejakul A., Vachalathiti R., and Poungvarin N. Botulinum treatment for post-stroke spasticity: low dose regime J.Med Assoc Thai 81 1998 413 422
64. Wagstaff A.J., and Bryson H.M. Tizanidine: A review of its pharmacology, clinical efficacy and tolerability in the management of spasticity associated with cerebral and spinal disorders Drugs 53 1997 435 452
65. Wallesch C.W., Maes E., Lecomte P., and Bartels C. Cost-effectiveness of botulinum toxin type A injection in patients with spasticity following stroke: a german perspective Eur J Neurology 4 suppl 2 1997 S53 S57
66. Wang H.C., Hsieh L.F., Chi W.C., and Lou S.M. Effect of intramuscular botulinum toxin injection on upper limb spasticity in stroke patients Am J phys Med Rehabil 81 2002 272 278
67. Ward A.B., Aguilar M., De Beyl Z., Gedin S., Kanovsky P., Molteni F., Wissel J., and Yakovleff A. Use of botulinum toxin type A in management of adult spasticity - A European consensus statement J Rehabil Med 35 2003 98 99
68. Woldag H., and Hummelsheim H. Is the reduction of spasticity by botulinum toxin a beneficial for the recovery of motor function of arm and hand in stroke patients? Eur Neurol 50 2003 165 171
69. Yelnik A.P., Colle F.M.C., and Bonan I.V. Treatment of pain and limited movement of the shoulder in hemiplegic patients with Botulinum toxin A in the subscapular muscle. Case reports Eur Neurol 50 2003 91 93